tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Amylyx price target raised to $14 from $10 at BofA

BofA analyst Tim Anderson raised the firm’s price target on Amylyx (AMLX) to $14 from $10 and keeps a Buy rating on the shares after the company reported Q2 results and reiterated it has a cash runway to the end of 2026. The firm’s higher target reflects changes in estimates, including a lower operating expense forecast in 2026, and updating its base valuation year to 2026.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1